Milky Way Investments: Funding, Team & Investors | Startup Intros

Loading organizations...

Milky Way Investments: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 8, 2026	Parabilis Medicines	$305.0M Series F	Jake Simson	Catalio Capital Management, Foresite Capital, ARCH Venture Partners, Cormorant Asset Management, Farallon Capital Management, Frazier Life Sciences, Freepoint Capital Group, General Catalyst, HBM Healthcare Investments, Invus, Marshall Wace, Nextech Invest, Rock Springs Capital, Sixty Degree Capital, Soleus Capital, T. Rowe Price Associates
Feb 1, 2024	FogPharma	$150.0M Series E	Thilo Schroeder	Lux Capital, Nextech Invest, The Column Group, venBio, Alex Gorsky, ARCH Venture Partners, Catalio Capital Management, Cormorant Asset Management, Farallon Capital Management, Fidelity Management & Research Company, Foresite Capital, General Catalyst, Google Ventures, Invus, Marshall Wace, RA Capital Management, Rock Springs Capital, Samsara BioCapital, Sixty Degree Capital, SymBiosis, T. Rowe Price Associates
Nov 1, 2022	FogPharma	$180.0M Series D	—	Nextech Invest, venBio, ARCH Venture Partners, Casdin Capital, Cormorant Asset Management, Deerfield Management, Farallon Capital Management, Fidelity Management & Research Company, Google Ventures, HBM Healthcare Investments, Invus, PagsGroup, T. Rowe Price Associates
Jan 7, 2021	LifeMine Therapeutics	$50.0M Series B	Richard Klausner, Milky Way Investments	ARCH Venture Partners, Blue Pool Capital, Foresite Capital, Google Ventures, MRL Ventures Fund, WuXi Healthcare Ventures
Mar 18, 2020	Cero Therapeutics	$40.0M Series A	—	Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner